cosmetics
Most Read
Pharmalittle: Biogen sells stake in biosimilars business for $2.3 billion; Lilly gives up on a lucrative idea
Break the stranglehold of the doctor-patient visit on health care innovation
Maximizing kidney transplant equity means minimizing geography
‘There’s no free lunch with drugs’: Janet Woodcock talks Covid monoclonal antibodies and pediatric vaccines
In ‘chemo brain,’ researchers see clues to unravel long Covid’s brain fog
‘Nowhere to hide’: As biotech stocks plummet, an industry is being reshaped by the fallout
